EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium

Karen Roksund Hov, Nils Bolstad, Ane-Victoria Idland, Henrik Zetterberg, Kaj Blennow, Farrukh A Chaudhry, Frede Frihagen, Johan Ræder, Torgeir Bruun Wyller, Leiv Otto Watne

Dementia and Geriatric Cognitive Disorders Extra · 09.11.2017 · 7 (3) · 374-385

DOI: 10.1159/000481853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders Extra, online erschienen am 09.11.2017. Verfasst von Karen Roksund Hov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to investigate the relationship between cerebrospinal fluid (CSF) S100B astrocyte-derived protein and delirium and to perform stratified analyses according to clinical and CSF markers of dementia.

Methods

We performed a prospective cohort study in a university hospital setting. The participants were patients admitted for hip fracture (n = 98) or for elective surgery (n = 50). Delirium was assessed daily perioperatively in hip fracture patients using the Confusion Assessment Method. A consensus-based diagnosis of prefracture dementia was made using all available information. CSF was drawn at the onset of spinal anesthesia. S100B and phosphorylated tau (P-tau) concentrations were measured using electrochemiluminescence immunoassay and enzyme-linked immunosorbent assays, respectively.

Results

In the hip fracture population (n = 98) there was no significant difference in CSF S100B concentrations between patients with ongoing preoperative (i.e., prevalent) delirium (n = 36, median [interquartile range] 1.11 μg/L [0.91–1.29]) and patients who never developed delirium (n = 46, 1.08 μg/L [0.92–1.28], p = 0.92). In patients without preoperative delirium, those who developed delirium postoperatively (i.e., incident delirium) (n = 16, 1.38 μg/L [1.08–1.62]) had higher concentrations of S100B than the 46 who never did (p = 0.013). This difference was confined to patients with pathological concentrations of P-tau (≥60 ng/L, n = 38). We also found that P-tau and S100B were correlated in CSF in the elective surgery patients.

Conclusions

CSF S100B was elevated in patients with incident delirium who also had pathological levels of the Alzheimer disease biomarker P-tau, suggesting vulnerability caused by a preexisting process of astrocytic activation and tau pathology.

Schlagwörter

Stichwörter der Autor:innen

Cerebrospinal fluidDeliriumHip fracturePhosphorylated tauS100B

Autor:innen und Institutionen

  • Oslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Oslo, Norway.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

Zitieren

APA

Hov, K. R., Bolstad, N., Idland, A. V., Zetterberg, H., Blennow, K., Chaudhry, F. A., Frihagen, F., Ræder, J., Wyller, T. B., & Watne, L. O. (2017). Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium. Dementia and Geriatric Cognitive Disorders Extra, 7(3), 374-385. https://doi.org/10.1159/000481853

Vancouver

Hov KR, Bolstad N, Idland AV, Zetterberg H, Blennow K, Chaudhry FA, et al. Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium. Dementia and Geriatric Cognitive Disorders Extra. 2017;7(3):374-385. doi:10.1159/000481853

BibTeX
@article{Hov2017,
  author = {Hov, Karen Roksund and Bolstad, Nils and Idland, Ane-Victoria and Zetterberg, Henrik and Blennow, Kaj and Chaudhry, Farrukh A and Frihagen, Frede and Ræder, Johan and Wyller, Torgeir Bruun and Watne, Leiv Otto},
  title = {Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium},
  journal = {Dementia and Geriatric Cognitive Disorders Extra},
  year = {2017},
  volume = {7},
  number = {3},
  pages = {374--385},
  doi = {10.1159/000481853}
}
Kostenlos starten →